Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
Abstract Neuroendocrine prostate cancer is an aggressive variant of prostate cancer that may arise de novo or develop from pre-existing prostate adenocarcinoma as a mechanism of treatment resistance. The combined loss of tumor suppressors RB1, TP53, and PTEN are frequent in NEPC but also present in...
Guardado en:
Autores principales: | Vincenza Conteduca, Sheng-Yu Ku, Luisa Fernandez, Angel Dago-Rodriquez, Jerry Lee, Adam Jendrisak, Megan Slade, Cole Gilbertson, Jyothi Manohar, Michael Sigouros, Yipeng Wang, Ryan Dittamore, Rick Wenstrup, Juan Miguel Mosquera, Joseph D. Schonhoft, Himisha Beltran |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/192f8c4983314673aa85a47274caaba0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
por: Vincenza Conteduca, et al.
Publicado: (2021) -
Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
por: Julie George, et al.
Publicado: (2018) -
Small cell neuroendocrine carcinoma expressing alpha fetoprotein in the endometrium
por: Hou Weiwei, et al.
Publicado: (2021) -
Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells
por: Xu-Dong Wang, et al.
Publicado: (2019) -
Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer
por: Ling Cai, et al.
Publicado: (2021)